Clinical Research Billing Platform Peppermint Secures $4.7 Million in Funding
AI-powered financial operations platform Peppermint has raised seed funding to optimize billing processes in clinical trials.
Peppermint, an AI-powered financial platform developed to improve billing and collection processes in clinical research, announced that it has secured $4.7 million in seed funding.
Details of the Investment Round
According to the announcement made by Peppermint, the company received $4.7 million in seed funding to develop its AI-based financial operations platform designed for clinical research teams.
Led by Moxxie, this investment round also saw participation from the company's co-founders David Freeman and VJ Thurimella.
Solutions Offered by the Platform
The platform developed by Peppermint maintains clinical research centers' earned revenues, visits, and invoices under a continuously audited record.